TLIS

Talis Biomedical Corporation (TLIS) | Rumor.io

Talis Biomedical

TLIS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about TLIS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 7

$TLIS is down 50% due to concerns about bankruptcy potential, despite having $45m in cash and zero debt.
A class action lawsuit is pending, with potential damages of $3.4m, and the outcome may impact the stock price.
The company's management and board are being criticized for poor communication and handling of litigation, which may be contributing to the stock's decline.

Generated by AI

Sentiment

Of the messages about TLIS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	97.22% +58.45
Bearish	—	—	—	2.78% -58.45

Jul 19

The company has a significant cash position of $112 million, which could be used to fuel growth and potentially lead to a significant increase in the stock price.
The stock has a low float of 1.5 million shares, which could lead to volatility and potentially drive the price up.
The stock has the potential to run from its current price to $10, based on a comparison with a similar stock that ran from $3 to $8 in the past.

Generated by AI

Topics

Of the messages about TLIS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	33.33%
Controversies	—	—	—	11.11%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	55.56%

Nov 14

Talis Biomedical Corporation is exploring strategic alternatives and implementing a cost reduction plan to preserve cash.
The company will close its California facility and cut approximately 90 jobs as part of the cost reduction plan.
The stock was halted on November 14, 2023, due to a news announcement related to the company's strategic alternatives and cost reduction plan.

Generated by AI

Community

Of the messages about TLIS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	64.29%
Newcomers	—	—	—	35.71%

Nov 14

Talis Biomedical is exploring strategic alternatives to preserve cash, and has implemented a cost reduction plan to achieve this goal.
The company is closing its California facility and cutting 90 jobs, which may impact its operations and workforce.
The closure of the California facility is part of the company's efforts to reduce costs and preserve cash, as it considers its strategic options.

Generated by AI

Also Discussed

Investors talking about TLIS also mention

#	Name	Attention
1	ACHL - Achilles Therapeutics plc	——
2	SYBX - Synlogic, Inc.	——
3	Kodiak Sciences Inc.KOD	0.07%-0.17
4	KRON - Kronos Bio, Inc.	——
5	Cibus Inc. Class A Common StockCBUS	0%0
6	Prelude Therapeutics IncorporatedPRLD	0%0
7	ANGN - Angion Biomedica Corp.	——
8	BTCY - Biotricity, Inc.	——
9	PBY - Prospect Capital Corporation	——
10	IGMS - IGM Biosciences, Inc.	——